MedTrace Logo

POSTERIOR SUB-TENON'S Avastin

NCT00567372 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2024-06-03

No results posted yet for this study

Summary

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

Conditions

  • Diffuse Diabetic Macular Edema

Interventions

DRUG

bevacizumab (Sub-tenon´s injection)

a single posterior sub-tenon's capsule injection of bevacizumab (2.5 mg /0.1ml)

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Sandra Vera, MD · Asociación para Evitar la Ceguera en Mexico

  • Hugo Quiroz-Mercado, MD · Denver Health Medical Center

  • Adai Pérez-Montesinos, MD · Asociación para Evitar la Ceguera en Mexico

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-11-30
Completion
2009-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567372 on ClinicalTrials.gov